Aerovate Therapeutics, Inc. logo

Aerovate Therapeutics, Inc.

NASDAQ:AVTE

Overview | Financials
Company Name Aerovate Therapeutics, Inc.
Symbol AVTE
Currency USD
Price 2.47
Market Cap 71,320,015
Dividend Yield 0%
52-week-range 1.25 - 32.415
Industry Biotechnology
Sector Healthcare
CEO Mr. Timothy P. Noyes M.B.A.
Website https://aerovatetx.com

About Aerovate Therapeutics, Inc.

Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. The company focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which is in

Related Stocks

Mersana Therapeutics, Inc. logo

Mersana Therapeutics, Inc.

MRSN

0.465 USD

Compass Therapeutics, Inc. logo

Compass Therapeutics, Inc.

CMPX

2.46 USD

Utah Medical Products, Inc. logo

Utah Medical Products, Inc.

UTMD

57.3 USD

Kezar Life Sciences, Inc. logo

Kezar Life Sciences, Inc.

KZR

5.87 USD

Icosavax, Inc. logo

Icosavax, Inc.

ICVX

15.31 USD

InterCure Ltd. logo

InterCure Ltd.

INCR

1.06 USD

Anika Therapeutics, Inc. logo

Anika Therapeutics, Inc.

ANIK

15.91 USD

EyePoint Pharmaceuticals, Inc. logo

EyePoint Pharmaceuticals, Inc.

EYPT

6.52 USD

Financials

Numbers are in millions USD

Numbers are in millions USD